Nutrition Management Services Company

Nutrition Management Services Company provides food, nutrition, and facilities management services in the United States. The company offers environmental management support solutions and cook/chill operation services. It serves long-term care facilities, independent and assisted living facilities, continuing care retirement communities, acute care hospitals, rehabilitation centers, and psychiatric and chemical dependency facilities, as well as nursing care centers and private schools. The company was founded in 1979 and is based in Kimberton, Pennsylvania.

Nutrition Management Services Company trades as NMSCA on OTC. The company is classified in Healthcare / Medical - Care Facilities and reports in USD.

The current profile places the business in Medical - Care Facilities. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Latest available fiscal data shows $20.01M of revenue and $85,369 of net income.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

Nutrition Management Services Company can be compared against peers such as Biocept, Inc., Biostar Pharmaceuticals, Inc., Plant-Based Investment Corp., Eloxx Pharmaceuticals, Inc., HTG Molecular Diagnostics, Inc., Nabriva Therapeutics plc.

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $854, beta of -14.18, and return on equity of +2.5%.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

NMSCA currently shows total debt of $5.28M and beta of -14.18. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

No recent SEC-style filings are available for this symbol yet.

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.nmsc.com

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.